Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to evaluate the usefulness of memantine, compared to placebo
(sugar pill), for the treatment of cognitive impairment in patients with idiopathic
Parkinson's disease (PD) and dementia. Memantine is used as a safe and effective treatment
for patients with Alzheimer's disease. Cognitive impairment includes concentration and memory
difficulties. We will look at how well this medication helps your cognitive impairment, how
well you tolerate this medication (including its effects on your motor symptoms of PD) your
activities of daily living, your emotions, and any medical conditions you might have. We will
interview a person you choose as your "informant".